Skip to content

Biofeedback Based Virtual Reality Intervention to Manage Postoperative Pain

Feasibility and Acceptability of a Biofeedback Based Virtual Reality Intervention to Manage Postoperative Pain in Children and Adolescents After Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04943874
Enrollment
93
Registered
2021-06-29
Start date
2022-03-10
Completion date
2025-08-22
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Pain, Acute, Pain, Postoperative, Surgery

Brief summary

To develop and refine a technology based treatment protocol for preoperative education and training and postoperative care in children and adolescents undergoing surgery.

Detailed description

This is a 2-phase study aimed to refine a perioperative treatment protocol for a technology-based intervention (Aim 1) and to understand whether technology-based interventions can be used to help treat pain in children following surgery (Aim 2). Patients will participate in only one phase of the study, and when patients are enrolled will determine what Phase of the study they are in. In Phase 1, all patients will use the same technology, and no randomization will occur. Primary and secondary outcome measures of Aim 1 are assessed in Phase 1. Actual enrollment for Phase 1 was 23 patients. In Phase 2, patients will be randomized to receive 1 of 2 technology-based interventions. The perioperative treatment protocol developed in Phase 1 (Aim 1) will be used in Phase 2 to assess the primary and secondary outcome measures of Aim 2. This phase is anticipated to enroll up to 70 participants. This is not an FDA-regulated drug or device trial as the technology used in this study is categorized as a relaxation device by the FDA and considered minimal risk, thus exempt from both NDE and IDE.

Interventions

DEVICETechnology Based Intervention Group 1

In Phase 1, all participants will use the same technology. In Phase 2, participants will be blinded to the two specific groups. They will not be aware of the technology used in the group they are not assigned too.

DEVICETechnology Based Intervention Group 2

Participants will be blinded to the two specific groups. They will not be aware of the technology used in the group they are not assigned too.

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Vanessa Olbrecht
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Ages 12 -18 years * Scheduled to undergo surgery anticipated to cause moderate to severe pain with expected length of stay \> or = to 2 days * Able to read, understand and speak English * Patients requiring management by the Acute Pain Service * Possession of a mobile device/computer available for study participation

Exclusion criteria

* Outside the age range (\< 12 or \> 18 years) * Non-English speaking * History of significant developmental delay, uncontrolled psychiatric conditions associated with hallucinations or delusions, or neurological conditions (especially epilepsy and/or significant motion sickness/nausea/vomiting) * History of vertigo, dizziness, seizure disorder, and/or severe motion sickness * History of chronic pain * Are chronically using opioids and or benzodiazepines for the management of pain * Are actively experiencing nausea or vomiting * Conditions such as craniofacial abnormalities or surgeries of the head and neck * Previous participation in this study

Design outcomes

Primary

MeasureTime frameDescription
Aim 1: Treatment protocol refinementDuration of study up to 30 daysFrequency of sessions
Aim 2: Feasibility of technology intervention in perioperative patientsPre-interventionRate of study recruitment

Secondary

MeasureTime frameDescription
Aim 2: Rate of study enrollment/randomizationPre-interventionAssessment of ability to enroll and randomize patients in pilot clinical trial
Aim 2: Rate of study retentionDuration of study up to 30 daysAssessment of ability to retain patients in pilot clinical trial
Aim 2: Rate of treatment adherenceDuration of study up to 30 daysAssessment of patient adherence to study protocol
Aim 2: Treatment-specific satisfactionPost intervention up to two weeksQualitative feedback from participants using questionnaire to assess intervention satisfaction
Aim 1: Preoperative training protocolUp to two weeks pre-operativelyFrequency of preoperative training session
Aim 2: Effect of technology on medication useDuration of hospital stay (2-7 days)Medications used will be collected
Aim 2: Effect of technology on painPreoperatively (up to 5 days)Pains scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Aim 2: Self-Reported OutcomesDay of hospital discharge (Postoperatively 2-7 days)Semi-structured interview
Aim 2: Effect of technology on anxiety30 minutes after using technologyAnxiety scores will be collected. Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
Aim 1: Post-operative session protocolUp to two week post surgeryFrequency of post-operative intervention session

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026